BeOne Medicines (ONC) Current Assets (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Current Assets data on file, last reported at $6.6 billion in Q1 2026.

• Quarterly Current Assets rose 69.42% year-over-year to $6.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.6 billion (up 69.42% YoY) and the FY2025 annual result came in at $6.2 billion, up 56.17% from the prior year.
• Current Assets improved to $6.6 billion in Q1 2026 per ONC's latest filing, from $6.2 billion in the prior quarter.
• Across five years, Current Assets topped out at $6.9 billion in Q1 2022 and bottomed at $3.1 billion in Q4 2022.
• The 5-year median for Current Assets is $4.3 billion (2025), against an average of $4.8 billion.
• The widest annual swing landed in 2022, when Current Assets sank 59.33%; it then surged 69.42% in 2026.
• Tracing ONC's Current Assets over 5 years: stood at $3.1 billion in 2022, then jumped by 35.74% to $4.2 billion in 2023, then retreated by 5.04% to $4.0 billion in 2024, then surged by 56.17% to $6.2 billion in 2025, then gained by 5.9% to $6.6 billion in 2026.
• Per Business Quant, the three latest ONC Current Assets figures stand at $6.6 billion (Q1 2026), $6.2 billion (Q4 2025), and $5.7 billion (Q3 2025).

Peer Comparison